PRKAR1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.031600E-01
Normal-vs-Stage2
3.716800E-01
Normal-vs-Stage3
3.725700E-02
Normal-vs-Stage4
7.835000E-01
Stage1-vs-Stage2
3.029600E-01
Stage1-vs-Stage3
1.092420E-01
Stage1-vs-Stage4
9.059600E-01
Stage2-vs-Stage3
2.344200E-01
Stage2-vs-Stage4
4.837200E-01
Stage3-vs-Stage4
6.551500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.013400E-01
Normal-vs-AfricanAmerican
8.889800E-01
Normal-vs-Asian
1.044180E-01
Caucasian-vs-AfricanAmerican
2.387600E-01
Caucasian-vs-Asian
2.216400E-01
AfricanAmerican-vs-Asian
6.206400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.807200E-01
Normal-vs-Female
4.476400E-01
Male-vs-Female
9.599400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.513800E-01
Normal-vs-Age(41-60Yrs)
9.969200E-01
Normal-vs-Age(61-80Yrs)
3.740200E-01
Normal-vs-Age(81-100Yrs)
4.030400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.756800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.470600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.984400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.001600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.238900E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.195220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.344300E-02
Normal-vs-Daily Drinker
9.103900E-02
Normal-vs-Weekly Drinker
1.536230E-01
Normal-vs-Occasional Drinker
9.226600E-01
Normal-vs-Social Drinker
8.675200E-01
Non Drinker-vs-Daily Drinker
8.374200E-01
Non Drinker-vs-Weekly Drinker
7.498800E-01
Non Drinker-vs-Occasional Drinker
3.267600E-02
Non Drinker-vs-Social Drinker
7.362400E-02
Daily Drinker-vs-Weekly Drinker
6.713600E-01
Daily Drinker-vs-Occasional Drinker
3.061600E-02
Daily Drinker-vs-Social Drinker
6.791600E-02
Weekly Drinker-vs-Occasional Drinker
6.377900E-02
Weekly Drinker-vs-Social Drinker
1.428410E-01
Occasional Drinker-vs-Social Drinker
6.623600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.250200E-01
Normal-vs-Grade 2
1.637800E-01
Normal-vs-Grade 3
1.451790E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.118450E-01
Grade 1-vs-Grade 3
2.383800E-01
Grade 1-vs-Grade 4
2.250200E-01
Grade 2-vs-Grade 3
5.099800E-01
Grade 2-vs-Grade 4
1.637800E-01
Grade 3-vs-Grade 4
1.451790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.372400E-01
Normal-vs-NonDiabetic
4.744000E-01
Diabetic-vs-NonDiabetic
4.321000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.562300E-02
Normal-vs-NoPancreatitis
4.881800E-01
Pancreatitis-vs-NoPancreatitis
5.215900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.167800E-01
Normal-vs-N1
3.852200E-01
N0-vs-N1
3.554400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.305000E-01
Normal-vs-TP53-NonMutant
7.503400E-01
TP53-Mutant-vs-TP53-NonMutant
2.042400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
